- Home
- XRTX vs NCPL Comparison
XRTX vs NCPL Comparison
Compare XRTX & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- NCPL
- Stock Information
- Founded
- XRTX 2011
- NCPL 1984
- Country
- XRTX Canada
- NCPL United States
- Employees
- XRTX N/A
- NCPL N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- NCPL Investment Managers
- Sector
- XRTX Health Care
- NCPL Finance
- Exchange
- XRTX Nasdaq
- NCPL Nasdaq
- Market Cap
- XRTX 4.2M
- NCPL 4.3M
- IPO Year
- XRTX N/A
- NCPL N/A
- Fundamental
- Price
- XRTX $0.89
- NCPL $7.98
- Analyst Decision
- XRTX
- NCPL
- Analyst Count
- XRTX 0
- NCPL 0
- Target Price
- XRTX N/A
- NCPL N/A
- AVG Volume (30 Days)
- XRTX 32.6K
- NCPL 630.6K
- Earning Date
- XRTX 08-13-2025
- NCPL 07-28-2025
- Dividend Yield
- XRTX N/A
- NCPL N/A
- EPS Growth
- XRTX N/A
- NCPL N/A
- EPS
- XRTX N/A
- NCPL N/A
- Revenue
- XRTX N/A
- NCPL $812,612.00
- Revenue This Year
- XRTX N/A
- NCPL N/A
- Revenue Next Year
- XRTX N/A
- NCPL $101.16
- P/E Ratio
- XRTX N/A
- NCPL N/A
- Revenue Growth
- XRTX N/A
- NCPL N/A
- 52 Week Low
- XRTX $0.80
- NCPL $1.41
- 52 Week High
- XRTX $2.98
- NCPL $11.90
- Technical
- Relative Strength Index (RSI)
- XRTX 54.28
- NCPL 82.77
- Support Level
- XRTX $0.80
- NCPL $3.90
- Resistance Level
- XRTX $0.98
- NCPL $7.55
- Average True Range (ATR)
- XRTX 0.05
- NCPL 0.87
- MACD
- XRTX 0.01
- NCPL 0.36
- Stochastic Oscillator
- XRTX 77.53
- NCPL 90.78
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.